Albus demonstrates device’s ability to detect asthma attacks in children
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs…
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs…
Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s…
AbbVie’s stock price fell over 12% after emraclidine, an investigational anti-psychotic being evaluated for the treatment of schizophrenia, failed to…
Alcon decided to take a platform-based approach to support its clinical transformation efforts when parent company Novartis decided to spin…
Ondine Biomedical will initiate a Phase III trial of its light-activated antimicrobial technology to reduce healthcare-associated infections (HAIs) early after…
Alloplex Biotherapeutics’ autologous SUPLEXA cell immunotherapy for cancer has demonstrated promise in a first-in-human study. In the Phase I trial,…
Medicines for Malaria Venture (MMV) and Quotient Sciences have dosed the first participants in a trial of MMV371, a long-acting…
The US National Institutes of Health (NIH) has launched a precision medicine trial that aims to match patients with myeloid…
Clinical stage biopharma company Kezar Life Sciences is discontinuing its LN clinical programme following the death of four patients. In…
NovoCure’s Optune Lua, a wearable indicated for use alongside PD-1/PD-L1 inhibitors (immunotherapy) or docetaxel in adult patients with metastatic non-small…